GNMXvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with GNMX, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNMX ETF 2 | +1.85%– | n/a– | n/a– | n/a– | n/a– | n/a– |
| Flows | GNMX ETF 2 | -– | -– | -– | -– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNMX ETF 2 | n/a– | n/a– | n/a– | n/a– |
| Max drawdown | GNMX ETF 2 | n/a– | n/a– | n/a– | n/a– |
| Max drawdown duration | GNMX ETF 2 | n/a– | n/a– | n/a– | n/a– |
Trading data
GNMX | ETF 2 | |
Last sale | – | |
| Previous close 07/24/2026 | – | |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
GNMX | ETF 2 | |
|---|---|---|
| Last price | – | – |
| 1D performance | – | – |
| AuM | $1.64 M | – |
| E/R | 0.35% | – |
Characteristics
GNMX | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Corgi Funds | – |
| Benchmark | - | – |
| N° of holdings | 57 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 6, 2026 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
GNMX
USA
89.37%
Other
10.63%
ETF 2
Sectors
GNMX
Healthcare
98.21%
Other
1.79%
ETF 2
Advertisement
Diversification
GNMX
Total weight of top 15 holdings out of 15
53.1%
ETF 2
–
Top 15 holdings
Data as of June 30, 2026
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
